Management guidelines and outcome measures in giant cell arteritis (GCA)

被引:0
|
作者
Warrington, K. J. [1 ]
Matteson, E. L. [1 ]
机构
[1] Mayo Clin, Coll Med, Div Rheumatol, Rochester, MN 55905 USA
关键词
vasculitis; giant cell arteritis; polymyalgia rheumatica; headache; corticosteroids; aneursym;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Giant cell arteritis (GCA) is a common form of vasculitis that predominantly affects the elderly. Cranial symptoms and elevated inflammatory markers are suggestive of the condition and the diagnosis is usually established by temporal artery biopsy. Corticosteroids are the mainstay of treatment for GCA and prolonged therapy is often necessary. Disease relapses and steroid-related adverse effects, however, are common. Serious complications of the disease may include visual loss, stroke, and aortic involvement with aneurysm formation.
引用
收藏
页码:S137 / S141
页数:5
相关论文
共 50 条
  • [1] Treatment of Giant Cell Arteritis (GCA)
    Regent, Alexis
    Mouthon, Luc
    JOURNAL OF CLINICAL MEDICINE, 2022, 11 (07)
  • [2] GIANT CELL ARTERITIS (GCA) IN OCTOGENARIAN PATIENTS
    Solans-Laque, R.
    Fonseca, E.
    Escalante, B.
    Martinez-Zapico, A.
    Fraile, G.
    Conesa, M.
    Abdilla, M.
    Monteagudo, M.
    Lasso, J.
    Calvo, E.
    Gracia, B.
    Castillo, M.
    Mestre, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 330 - 330
  • [3] Musculoskeletal manifestations in giant cell arteritis (GCA).
    Salvarani, C
    Gabriel, SE
    Hunder, GG
    Emilia, R
    ARTHRITIS AND RHEUMATISM, 1998, 41 (09): : S119 - S119
  • [4] THE ROLE OF ULTRASOUND IN THE MANAGEMENT OF GIANT CELL ARTERITIS (GCA) IN ROUTINE CLINICAL PRACTICE
    Monti, S.
    Floris, A.
    Ponte, C.
    Vaggers, S.
    Schmidt, W. A.
    Diamantopoulos, A. P.
    Pereira, C.
    Luqmani, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 315 - 315
  • [5] Giant cell arteritis: recent advances and guidelines for management
    Dasgupta, B.
    Hassan, N.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2007, 25 (01) : S62 - S65
  • [6] BSR and BHPR guidelines for the management of giant cell arteritis
    Dasgupta, Bhaskar
    Borg, Frances A.
    Hassan, Nada
    Alexander, Leslie
    Barraclough, Kevin
    Bourke, Brian
    Fulcher, Joan
    Hollywood, Jane
    Hutchings, Andrew
    James, Pat
    Kyle, Valerie
    Nott, Jennifer
    Power, Michael
    Samanta, Ash
    RHEUMATOLOGY, 2010, 49 (08) : 1594 - 1597
  • [7] Stroke as a Unique Complication of Giant Cell Arteritis (GCA)
    Chaku, Shilpa
    Dandapat, Sudeepta
    Siddiqui, Fazeel
    ANNALS OF NEUROLOGY, 2015, 78 : S74 - S74
  • [8] Occult GCA: A rare variant of Giant Cell Arteritis
    Huang, Lorenzo
    Fallahzadeh, Fariba
    Johannesson, Gauti
    ACTA OPHTHALMOLOGICA, 2024, 102 (08) : 968 - 973
  • [9] Giant Cell Arteritis (GCA): Do Not Forget the Aorta!
    Peet, Timothy M.
    Inderjeeth, Charles
    EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2021, 61 (03) : 501 - 501
  • [10] ALL WALES RE-AUDIT OF THE INITIAL MANAGEMENT OF GIANT CELL ARTERITIS (GCA)
    Rajak, Rizwan
    Bari, Farhan
    Hughes, Gwenan
    Thomas, Eleri
    RHEUMATOLOGY, 2012, 51 : 61 - 61